Eintrag weiter verarbeiten
Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627).
Gespeichert in:
| Zeitschriftentitel: | Journal of Clinical Oncology |
|---|---|
| Personen und Körperschaften: | , , , , , , , , |
| In: | Journal of Clinical Oncology, 34, 2016, 15_suppl, S. TPS620-TPS620 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
American Society of Clinical Oncology (ASCO)
|
| Schlagwörter: |
| author_facet |
Terranova Barberio, Manuela Thomas, Scott Chien, Amy Jo Rugo, Hope S. Melisko, Michelle E. Angelidakis, Austin Nicholas Pawlowska, Nela Deal, Travis Munster, Pamela N. Terranova Barberio, Manuela Thomas, Scott Chien, Amy Jo Rugo, Hope S. Melisko, Michelle E. Angelidakis, Austin Nicholas Pawlowska, Nela Deal, Travis Munster, Pamela N. |
|---|---|
| author |
Terranova Barberio, Manuela Thomas, Scott Chien, Amy Jo Rugo, Hope S. Melisko, Michelle E. Angelidakis, Austin Nicholas Pawlowska, Nela Deal, Travis Munster, Pamela N. |
| spellingShingle |
Terranova Barberio, Manuela Thomas, Scott Chien, Amy Jo Rugo, Hope S. Melisko, Michelle E. Angelidakis, Austin Nicholas Pawlowska, Nela Deal, Travis Munster, Pamela N. Journal of Clinical Oncology Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). Cancer Research Oncology |
| author_sort |
terranova barberio, manuela |
| spelling |
Terranova Barberio, Manuela Thomas, Scott Chien, Amy Jo Rugo, Hope S. Melisko, Michelle E. Angelidakis, Austin Nicholas Pawlowska, Nela Deal, Travis Munster, Pamela N. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps620 Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). Journal of Clinical Oncology |
| doi_str_mv |
10.1200/jco.2016.34.15_suppl.tps620 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC50cHM2MjA |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC50cHM2MjA |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 |
| imprint |
American Society of Clinical Oncology (ASCO), 2016 |
| imprint_str_mv |
American Society of Clinical Oncology (ASCO), 2016 |
| issn |
0732-183X 1527-7755 |
| issn_str_mv |
0732-183X 1527-7755 |
| language |
English |
| mega_collection |
American Society of Clinical Oncology (ASCO) (CrossRef) |
| match_str |
terranovabarberio2016phaseiitrialwithtamoxifenincombinationwithvorinostatandpembrolizumabinestrogenreceptorhormonetherapyresistantmetastaticbreastcancerpatientsnct02395627 |
| publishDateSort |
2016 |
| publisher |
American Society of Clinical Oncology (ASCO) |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Clinical Oncology |
| source_id |
49 |
| title |
Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_unstemmed |
Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_full |
Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_fullStr |
Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_full_unstemmed |
Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_short |
Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_sort |
phase ii trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (nct02395627). |
| topic |
Cancer Research Oncology |
| url |
http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps620 |
| publishDate |
2016 |
| physical |
TPS620-TPS620 |
| description |
|
| container_issue |
15_suppl |
| container_start_page |
0 |
| container_title |
Journal of Clinical Oncology |
| container_volume |
34 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792327144803663872 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T12:32:41.557Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Phase+II+trial+with+tamoxifen+in+combination+with+vorinostat+and+pembrolizumab+in+estrogen+receptor+%28%2B%29+hormone+therapy+resistant+metastatic+breast+cancer+patients+%28NCT02395627%29.&rft.date=2016-05-20&genre=article&issn=1527-7755&volume=34&issue=15_suppl&pages=TPS620-TPS620&jtitle=Journal+of+Clinical+Oncology&atitle=Phase+II+trial+with+tamoxifen+in+combination+with+vorinostat+and+pembrolizumab+in+estrogen+receptor+%28%2B%29+hormone+therapy+resistant+metastatic+breast+cancer+patients+%28NCT02395627%29.&aulast=Munster&aufirst=Pamela+N.&rft_id=info%3Adoi%2F10.1200%2Fjco.2016.34.15_suppl.tps620&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792327144803663872 |
| author | Terranova Barberio, Manuela, Thomas, Scott, Chien, Amy Jo, Rugo, Hope S., Melisko, Michelle E., Angelidakis, Austin Nicholas, Pawlowska, Nela, Deal, Travis, Munster, Pamela N. |
| author_facet | Terranova Barberio, Manuela, Thomas, Scott, Chien, Amy Jo, Rugo, Hope S., Melisko, Michelle E., Angelidakis, Austin Nicholas, Pawlowska, Nela, Deal, Travis, Munster, Pamela N., Terranova Barberio, Manuela, Thomas, Scott, Chien, Amy Jo, Rugo, Hope S., Melisko, Michelle E., Angelidakis, Austin Nicholas, Pawlowska, Nela, Deal, Travis, Munster, Pamela N. |
| author_sort | terranova barberio, manuela |
| container_issue | 15_suppl |
| container_start_page | 0 |
| container_title | Journal of Clinical Oncology |
| container_volume | 34 |
| description | |
| doi_str_mv | 10.1200/jco.2016.34.15_suppl.tps620 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTIwMC9qY28uMjAxNi4zNC4xNV9zdXBwbC50cHM2MjA |
| imprint | American Society of Clinical Oncology (ASCO), 2016 |
| imprint_str_mv | American Society of Clinical Oncology (ASCO), 2016 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161 |
| issn | 0732-183X, 1527-7755 |
| issn_str_mv | 0732-183X, 1527-7755 |
| language | English |
| last_indexed | 2024-03-01T12:32:41.557Z |
| match_str | terranovabarberio2016phaseiitrialwithtamoxifenincombinationwithvorinostatandpembrolizumabinestrogenreceptorhormonetherapyresistantmetastaticbreastcancerpatientsnct02395627 |
| mega_collection | American Society of Clinical Oncology (ASCO) (CrossRef) |
| physical | TPS620-TPS620 |
| publishDate | 2016 |
| publishDateSort | 2016 |
| publisher | American Society of Clinical Oncology (ASCO) |
| record_format | ai |
| recordtype | ai |
| series | Journal of Clinical Oncology |
| source_id | 49 |
| spelling | Terranova Barberio, Manuela Thomas, Scott Chien, Amy Jo Rugo, Hope S. Melisko, Michelle E. Angelidakis, Austin Nicholas Pawlowska, Nela Deal, Travis Munster, Pamela N. 0732-183X 1527-7755 American Society of Clinical Oncology (ASCO) Cancer Research Oncology http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps620 Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). Journal of Clinical Oncology |
| spellingShingle | Terranova Barberio, Manuela, Thomas, Scott, Chien, Amy Jo, Rugo, Hope S., Melisko, Michelle E., Angelidakis, Austin Nicholas, Pawlowska, Nela, Deal, Travis, Munster, Pamela N., Journal of Clinical Oncology, Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627)., Cancer Research, Oncology |
| title | Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_full | Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_fullStr | Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_full_unstemmed | Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_short | Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| title_sort | phase ii trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (nct02395627). |
| title_unstemmed | Phase II trial with tamoxifen in combination with vorinostat and pembrolizumab in estrogen receptor (+) hormone therapy resistant metastatic breast cancer patients (NCT02395627). |
| topic | Cancer Research, Oncology |
| url | http://dx.doi.org/10.1200/jco.2016.34.15_suppl.tps620 |